Correction Notice: Clarification on Early Stroke Recurrence Risk Management

Overview

This correction notice clarifies that neither statins nor early initiation of antihypertensive agents have demonstrated early benefits for patients with acute ischemic stroke. The updated information is crucial for guiding clinical practice in stroke management.

Background

Cite specific studies that demonstrate the lack of benefit from statins and antihypertensives.

Data Highlights

No numerical data provided in the article.

Key Findings

• Neither statins nor early initiation of antihypertensive agents have shown early benefit for acute ischemic stroke patients.
• Most early recurrences occur within 7 days, but initiating statins during this period does not reduce recurrence rates.
• Prior statin use may have a weak association with lower early recurrence, but initiation at the event shows no immediate protective effect.
• Early blood pressure lowering does not improve functional outcomes or mortality when initiated before hospital arrival.
• The 2025 ACC/AHA guidelines recommend against starting antihypertensives in the first 48–72 hours for certain AIS patients.

Clinical Implications

Clinicians should be cautious in prescribing statins and antihypertensives immediately after an acute ischemic stroke, as these interventions may not provide the anticipated benefits. Adhering to updated guidelines can help optimize patient management and improve outcomes.

Conclusion

This correction serves as an important reminder of the need for ongoing evaluation of treatment strategies in acute ischemic stroke. Evidence-based practices should guide clinical decisions to enhance patient care.

References

1. Author(s)/Org, Source, Year -- Title
2. Clinical Research in Cardiology — Managing Patients with Subclinical Atrial Fibrillation and Atrial High-Rate Episodes: Evidence and Clinical Significance
3. Clinical Research in Cardiology — Combined Effects of Oral Anticoagulation Management and Kidney Function on Major Adverse Events in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Findings from the AFCAS Registry
4. Endovascular Recanalization with Distal Protection for Symptomatic Chronic Occlusions of the Vertebrobasilar Artery
5. conexiant — Switching Anticoagulants After Breakthrough Stroke May Not Improve Outcomes
6. Statin initiation and early stroke recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial (POINT) trial population - PMC
7. Intensive versus standard blood pressure management after endovascular therapy in acute ischemic stroke: a systematic review and meta-analysis - PMC
8. Low-Density Lipoprotein Cholesterol Level, the Lower the Better? Analysis of Korean Patients in the Treat Stroke to Target Trial - PubMed
9. Prehospital blood pressure lowering in patients with ultra-acute presumed stroke: A systematic review and meta-analysis